0

Journal Articles

in Genetics
 161-180 of 844 Articles
JAMA Patient Page |  November 24, 2010 FREE
Gout
Ryszard M. Pluta, MD, PhD; Alison E. Burke, MA; Richard M. Glass, MD
JAMA. 2010;304(20):2314. doi:10.1001/jama.304.20.2413.
INCLUDES: , Supplemental Content
From the Centers for Disease Control and Prevention |  November 17, 2010 FREE
Update: Detection of a Verona Integron-Encoded Metallo-Beta- Lactamase in Klebsiella pneumoniae—United States, 2010
JAMA. 2010;304(19):2122. doi:.
Medical News and Perspectives |  November 10, 2010
Researchers Look to Genetic Analyses for New Options in Treating Food Allergy
Rebecca Voelker
JAMA. 2010;304(18):2001. doi:10.1001/jama.2010.1605.
Lab Reports |  November 03, 2010
Gene Silencing and Vasculitis
M. J. Friedrich
JAMA. 2010;304(17):1888. doi:10.1001/jama.2010.1519.
Editorial |  October 27, 2010
Clopidogrel and the Reduced-Function CYP2C19 Genetic Variant:  A Limited Piece of the Overall Therapeutic Puzzle
Valentin Fuster, MD, PhD; Joseph M. Sweeny, MD
JAMA. 2010;304(16):1839-1840. doi:10.1001/jama.2010.1566.
Health Agencies Update |  October 27, 2010
Pharmacogenetics Resources
Bridget M. Kuehn
JAMA. 2010;304(16):1777. doi:10.1001/jama.2010.1490.
Medical News and Perspectives |  October 27, 2010
National Children’s Study Expands
Bridget M. Kuehn
JAMA. 2010;304(16):1776. doi:10.1001/jama.2010.1502.
Original Contribution |  October 27, 2010 FREE
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock, MD; Derek J. Jonker, MD; Federica Di Nicolantonio, PhD; et al.
JAMA. 2010;304(16):1812-1820. doi:10.1001/jama.2010.1535.
INCLUDES: , Supplemental Content
Review |  October 27, 2010 FREE
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI:  A Meta-analysis
Jessica L. Mega, MD, MPH; Tabassome Simon, MD, PhD; Jean-Philippe Collet, MD, PhD; et al.
JAMA. 2010;304(16):1821-1830. doi:10.1001/jama.2010.1543.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  October 13, 2010
Genetic Research Provides Insights Into Age-Related Macular Degeneration
Tracy Hampton, PhD
JAMA. 2010;304(14):1541-1543. doi:10.1001/jama.2010.1411.
Medical News and Perspectives |  October 13, 2010
Seeing Is Believing
M. J. Friedrich
JAMA. 2010;304(14):1543-1545. doi:10.1001/jama.2010.1412.
Medical News and Perspectives |  September 22, 2010
Inconsistent Results, Inaccurate Claims Plague Direct-to-Consumer Gene Tests
Bridget M. Kuehn
JAMA. 2010;304(12):1313-1315. doi:10.1001/jama.2010.1328.
Original Contribution |  September 22, 2010 FREE
Association of Telomere Length of Peripheral Blood Leukocytes With Hematopoietic Relapse, Malignant Transformation, and Survival in Severe Aplastic Anemia
Phillip Scheinberg, MD; James N. Cooper, MD; Elaine M. Sloand, MD; et al.
JAMA. 2010;304(12):1358-1364. doi:10.1001/jama.2010.1376.
INCLUDES: , Supplemental Content
Commentary |  September 08, 2010
Exclusion of Genetic Information From the Medical Record:  Ethical and Medical Dilemmas
Robert Klitzman, MD
JAMA. 2010;304(10):1120-1121. doi:10.1001/jama.2010.1303.
Research Letters |  September 08, 2010 FREE
Pediatric Mortality Due to Inborn Errors of Metabolism in Victoria, Australia: A Population-Based Study
Himanshu Goel, MD; Allison Lusher, BHlthInfoManagement; Avihu Boneh, MD, PhD, FRACP
JAMA. 2010;304(10):1070-1072. doi:10.1001/jama.2010.1259.
Editorial |  September 01, 2010
Lessons Learned From Genetic Testing
Laura Esserman, MD, MBA; Virginia Kaklamani, MD, DSc
JAMA. 2010;304(9):1011-1012. doi:10.1001/jama.2010.1263.
Original Contribution |  September 01, 2010 FREE
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek, MD; Tara M. Friebel, MPH; Christian F. Singer, MD, MPH; et al.
JAMA. 2010;304(9):967-975. doi:10.1001/jama.2010.1237.
INCLUDES: , Supplemental Content
Original Contribution |  August 25, 2010 FREE
Genetic Variants of the Protein Kinase C-β 1 Gene and Development of End-Stage Renal Disease in Patients With Type 2 Diabetes
Ronald C. W. Ma, MB BChir; Claudia H. T. Tam, MPhil; Ying Wang, PhD; et al.
JAMA. 2010;304(8):881-889. doi:10.1001/jama.2010.1191.
INCLUDES: , Supplemental Content
Lab Reports |  August 18, 2010
Body Louse Genome
Tracy Hampton, PhD
JAMA. 2010;304(7):733. doi:10.1001/jama.2010.1081.
Lab Reports |  August 18, 2010
Treating Hereditary Blindness
Tracy Hampton, PhD
JAMA. 2010;304(7):733. doi:10.1001/jama.2010.1084.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  May 16, 2013
Phenotypic Conservation in Patients With X-Linked Retinitis Pigmentosa Caused by RPGR Mutations
Sarwar Zahid, MD, MS; Naheed Khan, PhD; Kari Branham, MS; et al.
JAMA Neurology
Original Contribution  |  May 13, 2013
Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs Without GBA Mutations
Lama M. Chahine, MD; Judy Qiang, BA; Emily Ashbridge; et al.
JAMA Neurology
Clinical Implications of Basic Neuroscience Research  |  May 13, 2013
TRIM Proteins in Therapeutic Membrane Repair of Muscular Dystrophy
Jenna Alloush; Noah Weisleder, PhD
JAMA Ophthalmology
Clinical Trials  |  May 9, 2013
Treatment With 9- cis β-Carotene–Rich Powder in Patients With Retinitis Pigmentosa:  A Randomized Crossover Trial
Ygal Rotenstreich, MD; Michael Belkin, MD; Siegal Sadetzki, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems